2024 European Society for Medical Oncology (ESMO) Annual Congress
ESMO 2024 Prostate Cancer
ESMO 2024 Bladder Cancer
ESMO 2024 Kidney Cancer
ESMO 2024 Testicular and Penile Cancer
ESMO 2024 Upper Tract Urothelial Carcinoma
ESMO 2024 Press Releases
- AVEO Oncology, an LG Chem company, Announces Acceptance of Late-Breaking Oral Presentation of TiNivo-2 Results at ESMO 2024
- Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio Research at ESMO 2024
- Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024